| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | CEP350 KIFAP3 SPTBN2 SYNE2 UNC5C CTNNA3 OBSCN AFDN MICAL3 MPRIP MSN | 6.87e-05 | 1099 | 50 | 11 | GO:0008092 |
| GeneOntologyMolecularFunction | actin binding | 1.79e-04 | 479 | 50 | 7 | GO:0003779 | |
| GeneOntologyMolecularFunction | cadherin binding | 1.55e-03 | 339 | 50 | 5 | GO:0045296 | |
| GeneOntologyMolecularFunction | actin filament binding | 2.49e-03 | 227 | 50 | 4 | GO:0051015 | |
| GeneOntologyBiologicalProcess | regulation of cell morphogenesis | 6.83e-06 | 302 | 49 | 7 | GO:0022604 | |
| Domain | CH | 7.02e-04 | 65 | 50 | 3 | SM00033 | |
| Domain | CH | 8.71e-04 | 70 | 50 | 3 | PF00307 | |
| Domain | - | 9.08e-04 | 71 | 50 | 3 | 1.10.418.10 | |
| Domain | CH | 9.84e-04 | 73 | 50 | 3 | PS50021 | |
| Domain | CH-domain | 1.06e-03 | 75 | 50 | 3 | IPR001715 | |
| Domain | Actinin_actin-bd_CS | 1.71e-03 | 23 | 50 | 2 | IPR001589 | |
| Domain | Spectrin | 1.71e-03 | 23 | 50 | 2 | PF00435 | |
| Domain | ACTININ_2 | 1.71e-03 | 23 | 50 | 2 | PS00020 | |
| Domain | ACTININ_1 | 1.71e-03 | 23 | 50 | 2 | PS00019 | |
| Domain | Spectrin_repeat | 2.72e-03 | 29 | 50 | 2 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 3.31e-03 | 32 | 50 | 2 | IPR018159 | |
| Domain | SPEC | 3.31e-03 | 32 | 50 | 2 | SM00150 | |
| Domain | - | 3.83e-03 | 391 | 50 | 5 | 2.30.29.30 | |
| Domain | PH_dom-like | 5.50e-03 | 426 | 50 | 5 | IPR011993 | |
| Domain | PH | 6.47e-03 | 278 | 50 | 4 | SM00233 | |
| Domain | PH_DOMAIN | 6.55e-03 | 279 | 50 | 4 | PS50003 | |
| Domain | PH_domain | 6.63e-03 | 280 | 50 | 4 | IPR001849 | |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | SPTBN2 UNC5C SANBR ZKSCAN8 ATG9A HSD17B4 PLXNB2 CNTROB EMSY MEN1 MSN | 8.00e-08 | 925 | 51 | 11 | 28986522 |
| Pubmed | 1.74e-07 | 421 | 51 | 8 | 36976175 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | USP34 ARHGEF40 WIZ NCAPD2 OBSCN MICAL3 ATG9A MAPKBP1 PLXNB2 CNTROB MPRIP | 4.71e-07 | 1105 | 51 | 11 | 35748872 |
| Pubmed | 5.23e-06 | 467 | 51 | 7 | 30194290 | ||
| Pubmed | Gene network analysis in a pediatric cohort identifies novel lung function genes. | 5.88e-06 | 24 | 51 | 3 | 24023788 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 16239140 | ||
| Pubmed | 9.87e-06 | 963 | 51 | 9 | 28671696 | ||
| Pubmed | CEP350 USP34 WIZ ENPP2 KRT222 SPTBN2 AFDN HSD17B4 TRIP11 MPRIP | 1.47e-05 | 1285 | 51 | 10 | 35914814 | |
| Pubmed | CEP350 WIZ STXBP3 SPTBN2 SYNE2 MICAL3 HSD17B4 SLC30A1 CNTROB | 1.94e-05 | 1049 | 51 | 9 | 27880917 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 3.17e-05 | 853 | 51 | 8 | 28718761 | |
| Pubmed | 4.41e-05 | 7 | 51 | 2 | 4397868 | ||
| Pubmed | Ciliary proteins Bbs8 and Ift20 promote planar cell polarity in the cochlea. | 9.42e-05 | 10 | 51 | 2 | 25605782 | |
| Pubmed | 1.33e-04 | 777 | 51 | 7 | 35844135 | ||
| Pubmed | 1.33e-04 | 67 | 51 | 3 | 29254152 | ||
| Pubmed | 1.48e-04 | 549 | 51 | 6 | 38280479 | ||
| Pubmed | Computational and experimental studies on human misshapen/NIK-related kinase MINK-1. | 1.63e-04 | 13 | 51 | 2 | 15032605 | |
| Pubmed | 1.84e-04 | 360 | 51 | 5 | 33111431 | ||
| Pubmed | Precise Somatotopic Thalamocortical Axon Guidance Depends on LPA-Mediated PRG-2/Radixin Signaling. | 1.90e-04 | 14 | 51 | 2 | 27641493 | |
| Pubmed | 2.83e-04 | 215 | 51 | 4 | 35973513 | ||
| Pubmed | 2.89e-04 | 87 | 51 | 3 | 12465718 | ||
| Pubmed | 3.19e-04 | 222 | 51 | 4 | 37071664 | ||
| Pubmed | 3.32e-04 | 638 | 51 | 6 | 31182584 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | 3.58e-04 | 647 | 51 | 6 | 26618866 | |
| Pubmed | 3.63e-04 | 1215 | 51 | 8 | 15146197 | ||
| Pubmed | 3.67e-04 | 650 | 51 | 6 | 38777146 | ||
| Pubmed | 3.76e-04 | 653 | 51 | 6 | 22586326 | ||
| Pubmed | 4.78e-04 | 22 | 51 | 2 | 34799561 | ||
| Pubmed | 6.70e-04 | 26 | 51 | 2 | 30378028 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 7.03e-04 | 1024 | 51 | 7 | 24711643 | |
| Pubmed | 7.78e-04 | 28 | 51 | 2 | 22002062 | ||
| Pubmed | 8.04e-04 | 1371 | 51 | 8 | 36244648 | ||
| Pubmed | 8.15e-04 | 285 | 51 | 4 | 34369648 | ||
| Pubmed | 8.35e-04 | 29 | 51 | 2 | 21998595 | ||
| Pubmed | 8.91e-04 | 128 | 51 | 3 | 30995482 | ||
| Pubmed | 8.93e-04 | 30 | 51 | 2 | 32562661 | ||
| Pubmed | 1.11e-03 | 1442 | 51 | 8 | 35575683 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | 1.16e-03 | 1451 | 51 | 8 | 30550785 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 1.30e-03 | 146 | 51 | 3 | 23892456 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 1.41e-03 | 565 | 51 | 5 | 25468996 | |
| Pubmed | 1.41e-03 | 1497 | 51 | 8 | 31527615 | ||
| Interaction | EPHA2 interactions | STXBP3 KRT222 UNC5C AFDN MICAL3 SLC30A1 PLXNB2 TRIP11 ALK MPRIP | 1.07e-05 | 719 | 51 | 10 | int:EPHA2 |
| Interaction | LTK interactions | 4.06e-05 | 152 | 51 | 5 | int:LTK | |
| Interaction | TOP3B interactions | USP34 ARHGEF40 WIZ SPTBN2 NCAPD2 OBSCN IREB2 MICAL3 ATG9A MAPKBP1 PLXNB2 CNTROB MPRIP | 5.44e-05 | 1470 | 51 | 13 | int:TOP3B |
| Interaction | NRAS interactions | 5.69e-05 | 699 | 51 | 9 | int:NRAS | |
| Interaction | APEX1 interactions | WIZ SPTBN2 UNC5C SANBR ZKSCAN8 ATG9A HSD17B4 PLXNB2 CNTROB EMSY MEN1 MSN | 5.99e-05 | 1271 | 51 | 12 | int:APEX1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p15 | 1.11e-03 | 44 | 51 | 2 | chr2p15 | |
| Coexpression | PGF_UP.V1_UP | 1.84e-06 | 190 | 51 | 6 | M2674 | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-06 | 174 | 51 | 5 | 55cc8300489d11322724159ec7d0e1d32a702e91 | |
| Drug | Pilocarpine nitrate [148-72-1]; Down 200; 14.8uM; HL60; HT_HG-U133A | 4.92e-06 | 196 | 51 | 6 | 2438_DN | |
| Drug | Niridazole [61-57-4]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 5.21e-06 | 198 | 51 | 6 | 5682_UP | |
| Disease | vital capacity | 2.05e-04 | 1236 | 50 | 9 | EFO_0004312 | |
| Disease | forced expiratory volume | 3.50e-04 | 789 | 50 | 7 | EFO_0004314 | |
| Disease | atrial fibrillation | 4.07e-04 | 371 | 50 | 5 | EFO_0000275 | |
| Disease | maximal midexpiratory flow rate | 5.24e-04 | 20 | 50 | 2 | EFO_0004313 | |
| Disease | cutaneous melanoma | 1.15e-03 | 121 | 50 | 3 | EFO_0000389 | |
| Disease | Papillary Renal Cell Carcinoma | 1.35e-03 | 128 | 50 | 3 | C1306837 | |
| Disease | Renal Cell Carcinoma | 1.35e-03 | 128 | 50 | 3 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 1.35e-03 | 128 | 50 | 3 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 1.35e-03 | 128 | 50 | 3 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 1.35e-03 | 128 | 50 | 3 | C1266044 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RDEERRKLADIIHHW | 6 | P55196 | |
| SHWVEIHQEVVRLCR | 671 | Q8TER5 | |
| AHEVVAHWIAESRIA | 666 | Q709F0 | |
| LQHHEAIIEEAEIRW | 126 | Q9H0I3 | |
| DIHDFEIILHRVEWA | 666 | Q04671 | |
| RWFERLQAIEHELHE | 266 | Q16769 | |
| LHDIWPSREEVHRVE | 661 | P48200 | |
| RDVHLALSEDHAWVV | 176 | O00255 | |
| IQADVHWTHIREREE | 1036 | Q7RTP6 | |
| DLKTHNVHVEIEQRW | 626 | Q6WCQ1 | |
| VEWVLEEVAQRSHAV | 141 | Q9Y5R4 | |
| RGEEWERHEALHEDV | 296 | Q96I76 | |
| REEWGRTLEDIFHEH | 251 | Q5XUX0 | |
| GERHALLEEENRVWH | 1576 | O15031 | |
| KEARRQWHHLQVEIE | 56 | Q8N1A0 | |
| VRAHEDAWHILVAKV | 191 | Q6ZS72 | |
| EAVTEEQAELRRWEH | 816 | Q86UK5 | |
| DQWEERIQVWHEEHR | 166 | P26038 | |
| SIIRWFEHEQNEREV | 216 | Q8NFY9 | |
| ELLWDVHSHVVRETT | 6326 | Q5VST9 | |
| WENHIHVLTEAVDDI | 486 | Q9UI47 | |
| EERAHQSILTQRVHW | 136 | Q5W0U4 | |
| ISDEDWDIIHRVHLR | 111 | P51659 | |
| AQAEPERHVWHRRES | 721 | Q7Z3C6 | |
| HILVQELHEEEAQWV | 3061 | Q5VT06 | |
| TWVRVSHEHLLQRVD | 121 | Q9UEW3 | |
| VHRDWRVHLALDVAN | 386 | Q7Z601 | |
| VRVWDVAEHSQVAEL | 116 | O60336 | |
| WEVTDHNLHELRVLR | 21 | Q9NV31 | |
| VVHVIASRRQDWSEH | 736 | Q7Z589 | |
| DGLWNRHHVERVEII | 226 | O95479 | |
| IEDIHLLVERRWHVA | 441 | Q13822 | |
| RVVEGWNRHEAERTE | 241 | Q8N137 | |
| IIDHELKRHELWQEE | 226 | Q92845 | |
| EDHQTWRNFIELVRE | 806 | Q9H2X9 | |
| EEEFRWLLHDEVHAV | 16 | Q9GZN7 | |
| VLKEQIEHLHRQWED | 5886 | Q8WXH0 | |
| QWDTEHVARVLLQHI | 121 | Q9Y2B2 | |
| IQEEWVRHLQRHILE | 1611 | O95785 | |
| RWEEVDISVHCDVHI | 186 | Q6NSI8 | |
| DDLWVRIRHRHIAVV | 286 | O00186 | |
| IEEEIRVNRSVHEWA | 801 | Q9UM73 | |
| IRHLWNHSIIEEEFV | 181 | Q15021 | |
| HQFHRDVEDEILWVT | 1491 | O15020 | |
| RSSVWKRETIVHQHE | 231 | P23025 | |
| DVRRVWLSSVVDHFH | 336 | Q96AP4 | |
| VSRLESEVGHWRHIA | 181 | Q15643 | |
| EELHLHAENLSRRVW | 1381 | Q70CQ2 | |
| RNVEGVEEVHELHVW | 361 | Q9Y6M5 | |
| NSEWVHQKDHIVDER | 96 | O95185 | |
| VTEEQRHIQEEHKWA | 1561 | Q6ZQQ6 | |
| QHADVSLSDVEWIRH | 2516 | Q6ZQQ6 | |
| SARVHGHRVLWEEVV | 141 | Q15776 |